CAP Issues Guideline to Ensure Accurate HPV Testing in Head and Neck Cancers

The College of American Pathologists (CAP) released its newest evidence-based practice guideline, "Human Papillomavirus (HPV) Testing in Head and Neck Carcinomas," on December 19, 2017.

The guideline, which recommends accurate assessment of a patient's high-risk HPV status, directly or by surrogate markers, was developed by an interdisciplinary, expert panel that included pathologists, surgeons, radiation oncologists, medical oncologists, patients, and patient advocates.

Based on a screening of 2,200 peer-reviewed articles and a review of evidence from 492 studies, the panel issued 14 final recommendations in the guideline.

Learn more on the CAP website.

Posted 1/3/2018